JPM 2021: Conformis Announces ACS Knee For 2H 2021, Integra Weathers Pandemic

The annual J.P. Morgan Healthcare Conference includes presentations from many major medtech companies outlining their growth strategies and expectations for 2021. Here are some of the highlights from the final day of the meeting.

Markus Augusti, president and CEO of orthopedics implant company Conformis, told investors during the J.P. Morgan Healthcare conference that the company is executing on its strategic pivot, announced in August, to develop and market “less-personalized” hip and knee products for treating patients in ambulatory care centers.

The trend toward moving knee and hip surgeries into the outpatient setting has been going on for some time. The...

More from Orthopedics

More from Device Area